ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,323,340 | -13.0% | 63,500 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,520,825 | +27.3% | 63,500 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,195,070 | +18.2% | 63,500 | 0.0% | 0.00% | +50.0% |
| Q4 2022 | $1,010,920 | +54.6% | 63,500 | +58.8% | 0.00% | 0.0% |
| Q3 2022 | $654,000 | -67.2% | 40,000 | -71.7% | 0.00% | -60.0% |
| Q2 2022 | $1,994,000 | +105.8% | 141,470 | +253.7% | 0.01% | +150.0% |
| Q1 2022 | $969,000 | +39.4% | 40,000 | +34.3% | 0.00% | +100.0% |
| Q4 2021 | $695,000 | -54.9% | 29,780 | -50.1% | 0.00% | -66.7% |
| Q1 2021 | $1,540,000 | -76.2% | 59,702 | -50.6% | 0.00% | -80.0% |
| Q4 2020 | $6,460,000 | +24.0% | 120,839 | -4.3% | 0.02% | +15.4% |
| Q3 2020 | $5,210,000 | +540.8% | 126,278 | +653.3% | 0.01% | +550.0% |
| Q2 2020 | $813,000 | +34.6% | 16,763 | +17.3% | 0.00% | 0.0% |
| Q1 2020 | $604,000 | – | 14,293 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
| Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
| Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
| SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
| HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
| Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
| Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
| EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
| WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |